Jounce Therapeutics, Inc. (JNCE)
(Delayed Data from NSDQ)
$5.79 USD
+0.42 (7.82%)
Updated May 3, 2019 04:00 PM ET
After-Market: $5.78 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For JNCE
-
Jounce Therapeutics Reports Third Quarter 2022 Financial Results
-
Jounce Therapeutics, Inc. (JNCE) Reports Q4 Loss, Lags Revenue Estimates
-
Analysts Estimate Jounce Therapeutics, Inc. (JNCE) to Report a Decline in Earnings: What to Look Out for
-
Jounce Therapeutics, Inc. (JNCE) Reports Q3 Loss, Lags Revenue Estimates
-
Jounce Therapeutics, Inc. (JNCE) Reports Q2 Loss, Tops Revenue Estimates
-
Jounce Therapeutics, Inc. (JNCE) Reports Q1 Loss, Misses Revenue Estimates
-
What's in Store for Jounce (JNCE) This Earnings Season?
-
Jounce Therapeutics, Inc. (JNCE) Q3 Earnings and Revenues Surpass Estimates
-
Jounce Therapeutics, Inc. (JNCE) Reports Q2 Loss, Tops Revenue Estimates
-
Jounce Therapeutics, Inc. (JNCE) Reports Q1 Loss, Misses Revenue Estimates
-
Will Jounce Therapeutics, Inc. (JNCE) Report Negative Q1 Earnings? What You Should Know
-
Jounce Therapeutics, Inc. (JNCE) Reports Q3 Loss, Tops Revenue Estimates
-
Analysts Estimate Jounce Therapeutics, Inc. (JNCE) to Report a Decline in Earnings: What to Look Out for
-
Jounce Therapeutics, Inc. (JNCE) Reports Q2 Loss, Tops Revenue Estimates